Related Experiment Video
Updated: Jun 30, 2026
11:13
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
38.8K
Clostridioides Difficile: A Concise Review of Best Practices and Updates
Abdelrahman Yakout1, Yan Bi1, Dana M Harris1
1Mayo Clinic, Jacksonville, FL, USA.
Journal of Primary Care & Community Health
|May 10, 2024
Summary
Clostridioides difficile infection (CDI) management is evolving with improved diagnostics and treatments. New guidelines favor fidaxomicin and emerging fecal microbiota therapies for better outcomes and reduced recurrence.
Area of Science:
- Infectious Diseases
- Microbiology
- Gastroenterology
Background:
- Clostridioides difficile infection (CDI) is a significant global healthcare-associated and community-acquired infection.
- Rising incidence necessitates advanced diagnostic and therapeutic strategies.
- Current management faces challenges with recurrence and treatment resistance.
Purpose of the Study:
- To provide an updated review of Clostridioides difficile infection (CDI) management strategies.
- To highlight recent advancements in diagnostics and therapeutics.
- To offer practical guidance for healthcare providers.
Main Methods:
- Review of current literature and clinical guidelines.
- Analysis of recent diagnostic advancements, including 2-step testing.
- Evaluation of updated treatment recommendations and novel therapies.
Main Results:
- 2-step testing enhances diagnostic specificity, optimizing antibiotic use.
- Fidaxomicin is now preferred over vancomycin/metronidazole for initial and recurrent CDI treatment.
- FDA-approved fecal microbiota therapies (RBX2660, SER-109) offer new prevention avenues.
Conclusions:
- Updated guidelines and novel therapies are improving CDI patient outcomes.
- Fidaxomicin demonstrates superior efficacy in reducing CDI recurrence.
- Microbiome-based therapies represent a promising frontier in CDI prevention and treatment.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:26Standard Precaution
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:19Key Techniques in Microbiology
Aseptic techniques prevent contamination, ensure experimental accuracy, and protect researchers and microbial cultures. These techniques are essential in clinical, industrial, and research settings where sterility is required.Maintaining Sterility in Laboratory PracticesScientists maintain sterility by sterilizing tools with heat or chemicals, disinfecting work surfaces, and handling cultures in controlled environments. Working near an open flame or within a laminar flow hood reduces the risk...